The organisation will discuss how its integrated approach aims to supports pharma companies at every stage of the drug development process
Stevanato Group, a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, will showcase its integrated solutions approach at CPhI Worldwide, November 9-11, 2021. The company will be exhibiting at Fiera Milano in Milan – in the InnoPack zone in Hall 6, Booth #G20.
SG Alina is a disposable, variable-dose pen injector platform compatible with established therapeutic regimens as well as more recent drug therapies related to diabetes care. It features a functional design, including an easy-to-dial mechanism, optimised injection force for patient comfort, and a readable display. The platform provides a range of customisation options from dosing and colour selection to a more industrial design based on the needs of the pharmaceutical client.
This device is just one example of the group's efforts to be a full solution provider. The organisation will also discuss how its integrated approach aims to supports pharma companies at every stage of the drug development process, from analytical services and drug containment solutions to automation and assembly equipment and contract manufacturing.
"The growing demand for customised products, produced faster and more cost effectively than ever before, means pharma companies are increasingly outsourcing activities to contract organisations," said Andrea Zambon, Corporate Business Development Director at Stevanato Group. "Our team is looking forward to highlighting the benefits of our full-service, integrated, flexible and modular approach for pharma companies large and small worldwide."